Biosimulation Market to Grow at a CAGR of 13.7% from 2023-2032 | Market.us
Market Overview The Global Biosimulation Market, valued at USD 3.3 billion in 2023, is forecasted to experience substantial growth, reaching an estimated USD 10.1 billion by 2032. This projection suggests a robust Compound Annual Growth Rate (CAGR) of 13.7% from 2023 to 2032. This significant growth can be attributed to several key factors, including the increasing adoption of biosimulation in drug development and discovery processes, advancements in technology that enhance simulation accuracy, and a growing emphasis on reducing the cost and time associated with bringing new drugs to market. The Biosimulation Market research report delivers essential data, offering clients the…
- Date: May 20, 2024
- Author: Thomas Bretz
- Category: PharmiWeb